Immunic Inc (IMUX) has gained Monday morning, with the stock increasing 1.96% in pre-market trading to 1.56. IMUX's short-term technical score of 41 indicates that the stock has traded less bullishly over the last month than 59% of stocks on the market. In the Biotechnology industry, which ranks 86 out of 146 industries, IMUX ranks higher than 51% of stocks. Immunic Inc has risen 25.41% over the past month, closing at $1.23 on February 12. During this period of time, the stock fell as low as $1.16 and as high as $1.64. IMUX has an average analyst recommendation of Strong Buy. The company has an average price target of $11.88.
IMUX has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on IMUX!